These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 3016581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
    Yokota N, Yamawaki S, Hayakawa H, Yoshida R, Sarai K.
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
    Nénonéné EK, Radja F, Carli M, Grondin L, Reader TA.
    J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
    [Abstract] [Full Text] [Related]

  • 9. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M.
    Eur J Pharmacol; 1995 Jan 16; 288(2):173-86. PubMed ID: 7720779
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino)chroman.
    Cossery JM, Gozlan H, Spampinato U, Perdicakis C, Guillaumet G, Pichat L, Hamon M.
    Eur J Pharmacol; 1987 Aug 11; 140(2):143-55. PubMed ID: 2959487
    [Abstract] [Full Text] [Related]

  • 14. Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT.
    Emerit MB, Gozlan H, Marquet A, Hamon M.
    Eur J Pharmacol; 1986 Aug 07; 127(1-2):67-81. PubMed ID: 2944752
    [Abstract] [Full Text] [Related]

  • 15. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats.
    Vergé D, Daval G, Marcinkiewicz M, Patey A, el Mestikawy S, Gozlan H, Hamon M.
    J Neurosci; 1986 Dec 07; 6(12):3474-82. PubMed ID: 2947981
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alkylation of [3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus.
    Nénonéné EK, Radja F, Carli M, van Gelder NM, Afkhami-Dastjerdian S, Reader TA.
    Neurochem Res; 1996 Feb 07; 21(2):167-76. PubMed ID: 9182242
    [Abstract] [Full Text] [Related]

  • 18. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.
    Beer M, Kennett GA, Curzon G.
    Eur J Pharmacol; 1990 Mar 20; 178(2):179-87. PubMed ID: 1691712
    [Abstract] [Full Text] [Related]

  • 19. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N, Lyon RA, Bullock AE, Rydelek LT, Titeler M, Glennon RA.
    J Med Chem; 1989 Jan 20; 32(1):253-6. PubMed ID: 2521252
    [Abstract] [Full Text] [Related]

  • 20. Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues.
    Harrington MA, Peroutka SJ.
    J Neurochem; 1990 Jan 20; 54(1):294-9. PubMed ID: 2136705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.